Biosense Webster has announced the launch of the new Thermocool SF NAV irrigated ablation catheter with new Curve Visualization in the United States.
The Thermocool SF NAV irrigated ablation catheter with Curve Visualization combines Biosense Webster’s latest porous tip technology with the accurate visualisation of the Carto3 3D Mapping & Ablation System. This enhanced technology is designed to reduce fluoroscopy exposure to physicians, lab staff and patients alike, enhance visualisation of the ablation catheters orientation and improve procedural efficiency.
Daniel Melby, cardiac electrophysiologist, Minneapolis Heart Institute in Minneapolis, was among the first to use the new technology in the United States, he said: “The Thermocool SF catheter with Curve Visualization provides substantial advantages over existing technologies. While using the Curve Visualization feature, the catheter position is more completely represented on the Carto display, thereby allowing less fluoroscopy use and easier catheter positioning on difficult atrial locations. In addition, the Thermocool SF catheter platform provides the ability to consistently ablate at all atrial locations without the limitation of overheating and with 50% less volume delivery to the patient.”
The innovative catheter design and breakthrough porous tip technology with Surround Flow technology of the Thermocool SF catheter allows for uniform cooling of the entire catheter tip, and efficient heat dissipation when ablating. This cutting edge innovation provides more effective cooling and allows half the volume load to the patient, when compared to the traditional Thermocool catheter.
The Thermocool SF NAV catheter is approved in the United States for treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation when used with Carto Systems and Type 1 atrial flutter for patients 18 years and older.
On 25–26 April 2012, Biosense Webster was invited to showcase the Thermocool SF catheter with Curve Visualization technology at the Innovation Expo of the HealthCare Leadership Council on Capitol Hill in Washington, DC, USA.
